文献速递神经康复

比较急性卒中在住院康复机构与专业护理机构进行康复的临床试验依据:挑战与机遇

Rationale for a Clinical Trial That Compares Acute Stroke Rehabilitation at Inpatient Rehabilitation Facilities to Skilled Nursing Facilities: Challenges and Opportunities.
PubMed 文献 · Arch Phys Med Rehabil · 2021-09-01

在美国,每年约40万急性卒中患者出院后转入住院康复机构(IRF)或专业护理机构(SNF)。IRF通常提供平均2-3周的强化治疗,SNF提供4-5周中等强度治疗。影响去向的因素复杂且认识不足,IRF康复费用约为SNF的两倍。现有证据质量低且异质性大,观察性数据无法控制残余混杂,亟需随机对照试验来比较两种机构的康复效果。

要点

  • IRF提供平均2-3周强化治疗,SNF提供4-5周中等强度治疗,IRF费用约为SNF两倍。
  • 观察性数据无法控制残余混杂,IRF与SNF康复比较效果证据质量低且异质性大。
  • 随机对照试验可均衡分布混杂因素,有助于明确哪些患者从各机构获益最大。

核心结论

  • 现有证据质量低且异质性大,无法确定IRF与SNF卒中康复的比较效果及获益人群。
  • 随机对照试验通过随机分配均衡混杂因素,是解决上述问题的关键设计。

研究设计与样本

  • 本文为论述性文章,讨论比较急性卒中后IRF与SNF康复的临床试验依据及设计挑战。
  • 原文未报告具体样本量或研究人群入选标准。

主要发现

  • 美国每年约40万急性卒中患者出院后转入IRF或SNF。
  • IRF通常提供平均2-3周时间密集型治疗,SNF提供4-5周中等强度治疗。
  • IRF卒中康复费用约为SNF的两倍。
  • 影响出院去向的因素是多方面的且认识不足,导致IRF与SNF使用存在巨大差异。

关键数值与推荐

  • 美国医学研究所指出,亟需政策改革以促进IRF与SNF的更高效使用,同时不损害结局。
  • 现有证据受限于观察性数据无法控制残余混杂,IRF与SNF康复获益幅度存在大量不确定性。

临床怎么用

  • 临床选择IRF或SNF时需考虑治疗强度与时长差异及费用差异。
  • 需认识到当前证据不足以明确哪些患者从IRF或SNF获益最大。

局限性

  • 现有比较证据多为观察性研究,无法控制残余混杂。
  • 影响IRF与SNF去向的因素复杂且主观临床指征导致使用差异大。
  • 原文未报告随机对照试验的具体结果数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the United States, approximately 400,000 patients with acute stroke are discharged annually to inpatient rehabilitation facilities (IRFs) or skilled nursing facilities (SNFs). Typically, IRFs provide time-intensive therapy for an average of 2-3 weeks, whereas SNFs provide more moderately intensive therapy for 4-5 weeks. The factors that influence discharge to an IRF or SNF are multifactorial and poorly understood. The complexity of these factors in combination with subjective clinical indications contributes to large variations in the use of IRFs and SNFs. This has significant financial implications for health care expenditure, given that stroke rehabilitation at IRFs costs approximately double that at SNFs. To control health care spending without compromising outcomes, the Institute of Medicine has stated that policy reforms that promote more efficient use of IRFs and SNFs are critically needed. A major barrier to the formulation of such policies is the highly variable and low-quality evidence for the comparative effectiveness of IRF- vs SNF-based stroke rehabilitation. The current evidence is limited by the inability of observational data to control for residual confounding, which contributes to substantial uncertainty around any magnitude of benefit for IRF- vs SNF-based care. Furthermore, it is unclear which specific patients would receive the most benefit from each setting. A randomized controlled trial addresses these issues, because random treatment allocation facilitates an equitable distribution of measured and unmeasured confounders. We discuss several measurement, practical, and ethical issues of a trial and provide our rationale for design suggestions that overcome some of these issues.

来源:Arch Phys Med Rehabil,查看原文。版权归原作者所有。

引用

  1. Simmonds KP, Burke J, Kozlowski AJ, et al. Rationale for a Clinical Trial That Compares Acute Stroke Rehabilitation at Inpatient Rehabilitation Facilities to Skilled Nursing Facilities: Challenges and Opportunities. Arch Phys Med Rehabil. 2021. PMID: 34480886. doi:10.1016/j.apmr.2021.08.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。